| Why Patents Matter Today A Practical Guide for Investors in Medical Technology Patents Define Value in MedTech In the medical device industry, patents are the core value driver. They: ● Block imitation ● Enable premium pricing ● Create licensing and royalty opportunities ● Serve as leverage in commercialization negotiations ● Protect clinical workflow innovation The Healing Spider platform is anchored by US 10,864,321 B1 and US 11,141,528 B1, which collectively secure fluid control, delivery, cartridge-based packaging, biologic compatibility, and therapeutic conditioning pathways. First-To-File Under the America Invents Act The America Invents Act (S.23) shifted the U.S. to a first-inventor-to-file system. This means: ● Market leadership goes to whoever files first ● Filing delays can forfeit entire product categories ● Venture-backed startups must prioritize rapid IP protection ● Large institutions now file aggressively to secure future dominance Because Healing Spider’s patents were filed in 2020–2021, they occupy an early, advantageous priority position in a rapidly growing domain—joint therapy, biologics, and photodynamic medical treatments. Why Financial Institutions Are Buying Patents Hedge funds, private equity, and IP aggregation firms increasingly treat medical patents as financial assets because: Patents behave like income-generating properties Licensing royalties act like predictable yield. Patents create strategic control They prevent competitors from blocking portfolio companies. Patents create bargaining power In negotiations, ownership of broad platform patents allows stronger positioning. Why the Healing Spider Patents Are Valuable A separate independent analysis firm (referenced in our internal materials) reviewed comparable IP transactions and observed: ● Estimate TAM range for this portfolio is currently north of $40B ● Strong, early-filed patents in expanding therapeutic markets receive disproportionate interest ● Patents covering both hardware architecture and therapy workflows are among the most sought after ● Portable biologics delivery, surgical adjunct devices, and PDT-compatible systems are currently on the rise sector-wide The Healing Spider patent family represents a full therapeutic platform, not a single-purpose device. This positions it extremely well for long-term defensibility, acquisition interest, and licensing leverage. |